Kaihui Liang, Nosratola D. Vaziri Kidney International

Slides:

Advertisements

Similar presentations

Volume 66, Issue 5, Pages (November 2004)

Advertisements

Volume 66, Issue 5, Pages (November 2004)

G1 kinases and transforming growth factor-β; signaling are associated with a growth pattern switch in diabetes-induced renal growth Hai-Chang Huang,

Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.

Toshiaki Monkawa, Tadashi Yoshida, Matsuhiko Hayashi, Takao Saruta

Cyril H. Barton, Zehnmin Ni, Nosratola D. Vaziri Kidney International

Volume 68, Issue 2, Pages (August 2005)

Volume 59, Issue 5, Pages (May 2001)

Lipopheresis in the nephrotic syndrome

Volume 71, Issue 3, Pages (February 2007)

Volume 67, Issue 5, Pages (May 2005)

Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.

Volume 78, Issue 10, Pages (November 2010)

Hua Liu, Steven A. Bigler, Jeffrey R. Henegar, Radhakrishna Baliga

Vitamin E attenuates crystal formation in rat kidneys: Roles of renal tubular cell death and crystallization inhibitors H.-S. Huang, J. Chen, C.-F. Chen,

Volume 66, Issue 5, Pages (November 2004)

Volume 65, Issue 1, Pages (January 2004)

Toshiaki Monkawa, Tadashi Yoshida, Matsuhiko Hayashi, Takao Saruta

Nosratola D. Vaziri, Kaihui Liang, Yaoxian Ding Kidney International

Hung-Chun Chen, Jinn-Yuh Guh, Juei-Hsiung Tsai, Yung-Hsiung Lai

Volume 63, Issue 2, Pages (February 2003)

Volume 60, Issue 2, Pages (August 2001)

Volume 60, Issue 5, Pages (November 2001)

Activation of Erk1/2 and Akt following unilateral ureteral obstruction

Volume 65, Issue 5, Pages (May 2004)

Down-regulation of Na+ transporters and AQP2 is responsible for acyclovir-induced polyuria and hypophosphatemia Lúcia Andrade, Nancy A. Rebouças, Antonio.

Volume 67, Issue 5, Pages (May 2005)

Volume 72, Issue 3, Pages (August 2007)

Volume 62, Issue 2, Pages (August 2002)

Volume 69, Issue 2, Pages (January 2006)

Wei-Zhong Ying, Paul W. Sanders Kidney International

Volume 66, Issue 2, Pages (August 2004)

Up-regulation of kidney NAD(P)H oxidase and calcineurin in SHR: Reversal by lifelong antioxidant supplementation Chang-de Zhan, Ram K. Sindhu, Nosratola.

Volume 57, Issue 5, Pages (May 2000)

P. Harding, L. Balasubramanian, J. Swegan, A. Stevens, W.F. Glass

Volume 70, Issue 4, Pages (August 2006)

Volume 56, Issue 2, Pages (August 1999)

Volume 63, Issue 1, Pages (January 2003)

Volume 87, Issue 1, Pages (January 2015)

Volume 58, Issue 2, Pages (August 2000)

Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo

Volume 65, Issue 3, Pages (March 2004)

Volume 70, Issue 4, Pages (August 2006)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Role of endothelin and nitric oxide imbalance in the pathogenesis of hypoxia-induced arterial hypertension Zhenmin Ni, Shahrooz Bemanian, Salah D. Kivlighn,

Jens Gaedeke, Nancy A. Noble, Wayne A. Border Kidney International

Choong Kim, Nosratola D. Vaziri Kidney International

Chien-Te Lee, Viet M. Huynh, Li-Wen Lai, Yeong-Hau H. Lien

Volume 71, Issue 4, Pages (February 2007)

Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier Ellen T. Mccarthy, R.A.M. Sharma, Mukut Sharma,

Mediterranean diets: are they practical in the Western world?

Endothelin antagonists in renal disease

Nosratola D. Vaziri, M.D., Kaihui Liang Kidney International

Volume 72, Issue 3, Pages (August 2007)

Cyril H. Barton, Zhemin Ni, Nosratola D. Vaziri Kidney International

Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis Nosratola D. Vaziri, Tadashi Sato, Kaihui Liang

Jens Gaedeke, Nancy A. Noble, Wayne A. Border Kidney International

Cell cycle regulation: Repair and regeneration in acute renal failure

IL-1β induces VEGF, independently of PGE2 induction, mainly through the PI3-K/mTOR pathway in renal mesangial cells D. Solà-Villà, M. Camacho, R. Solà,

Volume 58, Issue 6, Pages (December 2000)

T-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis Masashi Haraguchi, Wayne A. Border, Yufeng Huang,

Estrogen downregulates the proximal tubule type IIa sodium phosphate cotransporter causing phosphate wasting and hypophosphatemia S. Faroqui, M. Levi,

Volume 62, Issue 5, Pages (November 2002)

Volume 61, Issue 4, Pages (April 2002)

Volume 65, Issue 6, Pages (June 2004)

Volume 54, Issue 6, Pages (January 1998)

Volume 65, Issue 1, Pages (January 2004)

Volume 66, Issue 5, Pages (November 2004)

Volume 66, Issue 1, Pages (July 2004)

Presentation transcript:

Down-regulation of hepatic high-density lipoprotein receptor, SR-B1, in nephrotic syndrome Kaihui Liang, Nosratola D. Vaziri Kidney International Volume 56, Issue 2, Pages 621-626 (August 1999) DOI: 10.1046/j.1523-1755.1999.00585.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 (Upper panel) Representative Western blot of HDL receptor (HDLR) protein obtained in a placebo-treated rat (NL), a pre-nephrotic rat studied 24 hours after puromycin aminonucleoside (PAN) injection (D1), and the nephrotic animals studied on days 14 (D14) and 30 (D30) after initial PAN injection. (Lower panel) Group data reflecting relative optical densities of HDLR protein bands in the corresponding subgroups. N = 6 in each subgroup. *P < 0.01 vs. vales found in NL and D1 subgroups. Kidney International 1999 56, 621-626DOI: (10.1046/j.1523-1755.1999.00585.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 2 (Upper panel) Representative Northern blot of hepatic HDL receptor (HDL-R) mRNA and the corresponding actin mRNA in two nephrotic rats (NS) and two normal control rats (NL) studied 30 days after initial injections of puromycin aminonucleoside (PAN) or placebo, respectively. (Lower panel) Group data illustrating the hepatic HDL-receptor/actin mRNA in six nephrotic (NS) and six normal control (NL) rats obtained 30 days after initial injections of PAN and placebo, respectively. No significant difference was observed between the two groups. Kidney International 1999 56, 621-626DOI: (10.1046/j.1523-1755.1999.00585.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 3 (Upper panel) Representative Northern blots of hepatic apo A-I mRNA and actin mRNA in two nephrotic (NS) and two normal control (NL) animals studied 30 days after the initial injections of puromycin and placebo, respectively. (Lower panel) Group data depicting hepatic apo A-I/actin mRNA in nephrotic rats (NS) studied 30 days after initial injections of puromycin (N = 6) and normal controls (NL) studied 30 days after placebo injections (N = 6). *P < 0.01. Kidney International 1999 56, 621-626DOI: (10.1046/j.1523-1755.1999.00585.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 4 (A) Hepatic apo A-I/actin mRNA (ratio). (B) Hepatic high-density lipoprotein (HDL) receptor/actin mRNA (ratio) in rats studied 24 hours after intraperitoneal injections of puromycin aminonucleoside, 130 mg/kg (PAN), or vehicle (NL) alone. No significant difference was observed between the two subgroups. N = 6 in each subgroup. Kidney International 1999 56, 621-626DOI: (10.1046/j.1523-1755.1999.00585.x) Copyright © 1999 International Society of Nephrology Terms and Conditions